Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMC AMC Entertainment	$3.07 +1.5%	$3.02	$2.45 ▼ $5.76	$1.33B	1.5	11.46 million shs	9.71 million shs
AZN AstraZeneca	$69.85 -0.3%	$70.59	$61.24 ▼ $87.68	$216.63B	0.38	5.22 million shs	3.13 million shs
COSM Cosmos Health	$0.43 -2.3%	$0.44	$0.28 ▼ $1.58	$12.27M	5.33	547,918 shs	51,454 shs
GME GameStop	$23.59 -1.2%	$27.45	$18.73 ▼ $35.81	$10.55B	-0.69	11.43 million shs	11.56 million shs
GSK GSK	$38.55 0.0%	$38.86	$31.72 ▼ $44.67	$78.99B	0.52	4.91 million shs	4.92 million shs
PFE Pfizer	$24.20 -0.2%	$23.46	$20.92 ▼ $31.54	$137.53B	0.57	41.37 million shs	39.50 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMC AMC Entertainment	+2.00%	+2.00%	-11.16%	+6.61%	-34.44%
AZN AstraZeneca	-0.31%	-0.14%	-0.75%	-5.34%	-11.67%
COSM Cosmos Health	-2.29%	-1.11%	-9.31%	-5.34%	-33.81%
GME GameStop	-1.06%	+0.60%	-24.29%	+8.39%	-2.44%
GSK GSK	-0.13%	+1.45%	-1.72%	-0.51%	-0.84%
PFE Pfizer	-0.44%	+0.95%	+4.38%	-3.99%	-11.76%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMC AMC Entertainment	3.0863 of 5 stars	2.9	2.0	0.0	3.5	1.7	0.0	0.6
AZN AstraZeneca	2.2804 of 5 stars	2.4	3.0	1.7	0.0	2.9	0.0	1.3
COSM Cosmos Health	1.5798 of 5 stars	0.0	3.0	0.0	0.0	2.4	2.5	1.3
GME GameStop	1.7259 of 5 stars	0.5	1.0	0.0	2.1	1.1	2.5	1.9
GSK GSK	2.031 of 5 stars	1.1	4.0	2.5	0.0	1.9	0.0	2.5
PFE Pfizer	4.8583 of 5 stars	2.3	3.0	4.2	4.3	2.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMC AMC Entertainment	1.75	Reduce	$4.26	39.13% Upside
AZN AstraZeneca	2.83	Moderate Buy	$85.00	21.69% Upside
COSM Cosmos Health	0.00	N/A	N/A	N/A
GME GameStop	1.00	Sell	$13.50	-42.77% Downside
GSK GSK	2.10	Hold	$37.38	-3.04% Downside
PFE Pfizer	2.53	Moderate Buy	$29.17	20.54% Upside

Current Analyst Ratings Breakdown

Latest COSM, GME, AMC, PFE, GSK, and AZN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/11/2025	GME GameStop	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform	$13.50
6/3/2025	GSK GSK	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
5/29/2025	AMC AMC Entertainment	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$2.30 ➝ $2.60
5/16/2025	AMC AMC Entertainment	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$3.00
5/15/2025	AMC AMC Entertainment	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
4/30/2025	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$24.00 ➝ $25.00
4/28/2025	GSK GSK	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell
4/24/2025	AMC AMC Entertainment	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$2.80 ➝ $2.30
4/22/2025	PFE Pfizer	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight ➝ Neutral	$24.00
4/16/2025	AMC AMC Entertainment	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$3.25 ➝ $3.00
4/15/2025	AZN AstraZeneca	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$75.00

(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMC AMC Entertainment	$4.64B	0.29	N/A	N/A	($4.25) per share	-0.72
AZN AstraZeneca	$54.07B	4.01	$6.29 per share	11.10	$13.18 per share	5.30
COSM Cosmos Health	$54.43M	0.23	$0.12 per share	3.68	$1.05 per share	0.41
GME GameStop	$3.82B	2.76	$0.38 per share	61.96	$11.15 per share	2.12
GSK GSK	$40.10B	1.97	$5.57 per share	6.92	$8.07 per share	4.78
PFE Pfizer	$63.63B	2.16	$4.37 per share	5.54	$15.62 per share	1.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMC AMC Entertainment	-$352.60M	-$0.98	0.00	N/A	N/A	-8.60%	N/A	-5.68%	8/1/2025 (Estimated)
AZN AstraZeneca	$7.04B	$2.49	16.17	13.97	1.28	14.14%	33.14%	12.83%	7/24/2025 (Estimated)
COSM Cosmos Health	-$16.18M	-$1.08	0.00	42.69	N/A	-28.26%	-17.25%	-8.57%	8/5/2025 (Estimated)
GME GameStop	$131.30M	$0.46	51.28	131.06	N/A	5.67%	5.25%	3.99%	9/9/2025 (Estimated)
GSK GSK	$3.29B	$1.94	19.87	8.29	1.35	9.89%	48.82%	11.15%	7/30/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	17.53	7.99	0.88	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest COSM, GME, AMC, PFE, GSK, and AZN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	N/A	N/A
6/10/2025	Q1 2025	GME GameStop	$0.04	$0.17	+$0.13	$0.09	$754.23 million	$732.40 million
5/15/2025	Q1 2025	COSM Cosmos Health	N/A	$0.01	N/A	-$0.03	N/A	N/A
5/7/2025	Q1 2025	AMC AMC Entertainment	-$0.61	-$0.58	+$0.03	-$0.47	$983.23 million	$862.50 million
4/30/2025	Q1 2025	GSK GSK	$1.08	$1.13	+$0.05	$1.00	$7.52 billion	$10.06 billion
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/15/2025	Q4 2024	COSM Cosmos Health	-$0.09	-$0.08	+$0.01	-$0.45	$14.50 million	$14.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMC AMC Entertainment	N/A	N/A	N/A	N/A	N/A
AZN AstraZeneca	$2.06	2.95%	N/A	82.73%	N/A
COSM Cosmos Health	N/A	N/A	N/A	N/A	N/A
GME GameStop	N/A	N/A	N/A	N/A	N/A
GSK GSK	$1.69	4.38%	N/A	87.11%	N/A
PFE Pfizer	$1.72	7.11%	N/A	124.64%	16 Years

Latest COSM, GME, AMC, PFE, GSK, and AZN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
5/2/2025	GSK GSK	quarterly	$0.4216	4.1%	5/16/2025	5/16/2025	7/10/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMC AMC Entertainment	N/A	0.42	0.42
AZN AstraZeneca	0.65	0.90	0.70
COSM Cosmos Health	0.08	1.05	0.87
GME GameStop	0.30	8.39	7.89
GSK GSK	1.21	0.87	0.58
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMC AMC Entertainment	28.80%
AZN AstraZeneca	20.35%
COSM Cosmos Health	12.61%
GME GameStop	29.21%
GSK GSK	15.74%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
AMC AMC Entertainment	0.32%
AZN AstraZeneca	N/A
COSM Cosmos Health	15.61%
GME GameStop	12.28%
GSK GSK	10.00%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMC AMC Entertainment	33,382	431.95 million	430.57 million	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
COSM Cosmos Health	100	28.75 million	24.26 million	Optionable
GME GameStop	6,000	447.34 million	392.40 million	Optionable
GSK GSK	68,629	2.05 billion	1.84 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

COSM, GME, AMC, PFE, GSK, and AZN Headlines

Recent News About These Companies

Pfizer’s Bold Clinical Trials Could Boost Stock Performance

June 28 at 11:25 AM | tipranks.com

Sumitomo Mitsui Trust Group Inc. Sells 941,490 Shares of Pfizer Inc. (NYSE:PFE)

June 28 at 8:17 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Sold by Sunbelt Securities Inc.

June 28 at 6:56 AM | marketbeat.com

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

June 28 at 6:38 AM | msn.com

3 No-Brainer Stocks to Buy for Under $100 Right Now

June 28 at 6:35 AM | fool.com

BSW Wealth Partners Acquires 17,274 Shares of Pfizer Inc. (NYSE:PFE)

June 28 at 6:30 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by QSM Asset Management Ltd

June 28 at 5:44 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Achmea Investment Management B.V.

June 28 at 5:26 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Bought by Illinois Municipal Retirement Fund

June 28 at 5:17 AM | marketbeat.com

Perpetual Ltd Grows Stake in Pfizer Inc. (NYSE:PFE)

June 28 at 4:46 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Holdings Lifted by Bessemer Group Inc.

June 28 at 4:03 AM | marketbeat.com

Pfizer reports positive results from Phase III BAISIS trial for haemophilia

June 27 at 8:37 PM | msn.com

5 Recession-Proof Dividend Stocks With Yields Over 6%

June 27 at 4:15 PM | 247wallst.com

Pfizer's bleeding disorder therapy succeeds in trial with patients with certain antibodies

June 27 at 3:35 PM | msn.com

Pfizer’s New Clinical Study on PF-07985631: A Potential Game-Changer for Kidney Disease

June 27 at 12:56 PM | tipranks.com

Pfizer’s Prevnar 20 Study: A Potential Game-Changer for Elderly Pneumonia Prevention

June 27 at 12:09 PM | tipranks.com

PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

June 27 at 12:00 PM | zacks.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Philip James Wealth Mangement LLC

June 27 at 8:17 AM | marketbeat.com

Quilter Plc Reduces Stake in Pfizer Inc. (NYSE:PFE)

June 27 at 8:06 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Artemis Investment Management LLP

June 27 at 7:55 AM | marketbeat.com

Pfizer Reveals Positive Phase 3 Results for HYMPAVZI

June 27 at 7:33 AM | miragenews.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
By Ryan Hasson | June 3, 2025
View Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
FedEx Stock Is at Its Bottom—And It May Be Time to Buy
By Thomas Hughes | June 26, 2025
View FedEx Stock Is at Its Bottom—And It May Be Time to Buy
GameStop Turns a Profit, But Core Business Keeps Shrinking
By Thomas Hughes | June 12, 2025
View GameStop Turns a Profit, But Core Business Keeps Shrinking

COSM, GME, AMC, PFE, GSK, and AZN Company Descriptions

AMC Entertainment NYSE:AMC

$3.06 +0.05 (+1.49%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$3.06 0.00 (-0.16%)

As of 06/27/2025 07:59 PM Eastern

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. It owns, operates, or has interests in theatres in the United States and Europe. The company was founded in 1920 and is headquartered in Leawood, Kansas.

AstraZeneca NASDAQ:AZN

$69.85 -0.22 (-0.31%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$70.10 +0.25 (+0.35%)

As of 06/27/2025 07:59 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Cosmos Health NASDAQ:COSM

$0.43 -0.01 (-2.29%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$0.42 0.00 (-0.68%)

As of 06/27/2025 07:20 PM Eastern

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

GameStop NYSE:GME

$23.59 -0.29 (-1.21%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$23.64 +0.05 (+0.23%)

As of 06/27/2025 08:00 PM Eastern

GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.

GSK NYSE:GSK

$38.54 -0.01 (-0.01%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$38.70 +0.15 (+0.39%)

As of 06/27/2025 07:56 PM Eastern

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Pfizer NYSE:PFE

$24.20 -0.04 (-0.18%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$24.18 -0.02 (-0.07%)

As of 06/27/2025 08:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest COSM, GME, AMC, PFE, GSK, and AZN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest COSM, GME, AMC, PFE, GSK, and AZN Earnings

Compare Dividends

Latest COSM, GME, AMC, PFE, GSK, and AZN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

COSM, GME, AMC, PFE, GSK, and AZN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

COSM, GME, AMC, PFE, GSK, and AZN Company Descriptions

AMC Entertainment NYSE:AMC

AstraZeneca NASDAQ:AZN

Cosmos Health NASDAQ:COSM

GameStop NYSE:GME

GSK NYSE:GSK

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools